Evaluation of the expression of β-catenin and cyclin D1 markers depending on the clinical and morphological characteristics and proliferative activity of colorectal carcinomas

Authors

DOI:

https://doi.org/10.26641/1997-9665.2022.4.32-40

Keywords:

colorectal carcinoma, digital morphometry, β-catenin, cyclin D1, Ki-67

Abstract

Background. Colorectal cancer (CRC) is the third most common malignancy in the world and the fourth most common cause of death from all cancers. The progression of neoplasia in the large intestine depends on a sequence of genetic errors that eventually lead to the appearance of malignant tumors. The earliest known mutation in this progression is the inactivation of the polyposis coli adenomatous tumor suppressor gene. It is important to identify molecular prognostic markers for prognosis, which will help in choosing a therapeutic course of strategy and further improving the survival of patients with CRC. Much attention has been paid to the involvement of cyclin D1 in tumor development and progression. The aim of the study was to evaluate the prognostic significance of the expression of β-catenin and cyclin D1 markers depending on the clinical and morphological characteristics and proliferative activity of colorectal carcinomas. Methods. In the work, the clinical and anatomical material of CRC of 37 patients (15 women and 22 men) who were treated in the 2nd surgical department of the ME “Dnipropetrovsk Regional Clinical Hospital named after I.I. Mechnikova”, Dnipro, Ukraine, in the period from 2019 to 2021. The age of the patients ranged from 27 to 82 years, the average age was 61.43±14.90 years. Primary monoclonal antibodies to Ki-67 (sp6, 1:250), β-catenin (Beta Catenin – 1, clone EP35, RTU), cyclin D1 (clone EP12, RTU) and the UltraVision Quanto imaging system, (LabVision) were used for immunohistochemical research. The photographed fields of view were processed in the Fiji platform with the calculation of the percentages of Ki-67 and cyclin D1 positive intranuclear reactions with the ImmunoRatio plugin. Results. The distribution of variants of typical (membrane) and aberrant (cytoplasmic or cytoplasmic-nuclear) expression of the β-catenin marker demonstrated a significant difference in subgroups of colorectal carcinomas G2 / G3 according to the degree of differentiation (p<0.05), in subgroups with / without metastases (p<0.05) and in subgroups of carcinomas with different proliferative activity (p<0.05). Aberrant (nuclear-cytoplasmic, nuclear dot-like and cytoplasmic with empty nuclei) expression of cyclin D1 in colorectal carcinomas was found much less often (8 out of 37; 21.62%) compared to the β-catenin marker, where atypical reactions accounted for more than half of all cases (24 out of 37; 64.86%). A statistically significant difference in the distribution of aberrant expressions of cyclin D1 was shown in subgroups with different localization (right-sided / left-sided) (p<0.05) and in subgroups with different proliferative activity according to Ki-67 (p<0.05). The highest percentage of high expression of cyclin D1 was demonstrated by right-sided colorectal carcinomas (p<0.05), carcinomas with a moderate degree of G2 differentiation (p<0.05), the subgroup without metastases (p<0.05) and cases of carcinomas with Ki-67 expression >25% (p<0.05).

References

  1. Granados-Romero JJ, Valderrama-Treviño AI, Contreras-Flores EH, et al. Colorectal cancer: a review. International Journal of Research in Medical Sciences. 2017;5(11):4667-4676. DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20174914.
  2. Takayama T, Shiozaki H, Doki Y, et al. Ab-errant expression and phosphorylation of β-catenin in human colorectal cancer. British Journal of Cancer. 1998;77(7):605-613. https://doi.org/10.1038/bjc.1998.97.
  3. Alexander PG, Matly AAM, Jirapongwattana N, et al. The relationship between the Glasgow Microenvironment Score and markers of epithelial-mesenchymal transition in TNM II-III colorectal cancer. Human Pathology. 2022;127:1-11. https://doi.org/10.1016/j.humpath.2022.05.012.
  4. Fedorenko ZP, Hulak LO, Mykhailovych YuY, et al. [Cancer in Ukraine, 2019-2020. Morbidity, mortality, performance indicators of the oncology service]. Bulletin of the National Chancery Register of Ukraine. 2021;22. Ukrai-nian.http://www.ncru.inf.ua/publications/BULL_22/.
  5. Miyamoto S, Endoh Y, Hasebe T, et al. Nuclear β-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers. Oncology Reports. 2004;12(2):245-251. https://doi.org/10.3892/or.12.2.245.
  6. Herter P, Kuhnen C, Müller K-M, et al. Intracellular distribution of β-catenin in colorectal adenomas, carcinomas and Peutz-Jeghers polyps. Journal of Cancer Research and Clinical Oncology. 1999;125:297-304. https://doi.org/10.1007/s004320050277.
  7. Abdulrahman ZA, Ismael AT, Jalal JA, Al-nuaimy WMT. Significance of B-catenin Immuno-histochemical Expression in Colorectal Carcinoma. Journal of Kurdistan Board of Medical Specialties. 2018;4(1):51-56.
  8. Yang Li, Jun Wei, Chuanhui Xu, et al. Prognostic Significance of Cyclin D1 Expression in Colorectal Cancer: A Meta-Analysis of Observational Studies. PLoS ONE. 2014;9(4):e94508. doi:10.1371/journal.pone.0094508.
  9. Amani Kazem, Khaled El Sayed, Yasser El Kerm. Prognostic significance of COX-2 and b-catenin in colorectal carcinoma. 2014;50:211-220.
  10. Albasri AM, Elkablawy MA, Ansari IA, Alhujaily AS. Prognostic Significance of Cyclin D1 Over-expression in Colorectal Cancer: An Experience from Madinah, Saudi Arabia. Asian Pac J Cancer Prev. 2019;20(8):2471-2476. doi: 10.31557/APJCP.2019.20.8.2471.
  11. Li Yang, Xiaoqing Tian, Xiang Chen, et al. Upregulation of Rab31 is associated with poor prognosis and promotes colorectal carcinoma proliferation via the mTOR/p70S6K/Cyclin D1 signalling pathway. Life Sciences. 2020;257: 118126. https://doi.org/10.1016/j.lfs.2020.118126.
  12. Ling Cao, Yulin Liu, Dan Wang, et al. MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling. Journal of Experimental & Clinical Cancer Research. 2018;37(83):1-14. https://doi.org/10.1186/s13046-018-0757-8.
  13. Su Y, Shrubsole MJ, Ness RM, et al. Immunohistochemical Expressions of Ki-67, Cyclin D1, β-Catenin, Cyclooxygenase-2, and Epidermal Growth Factor Receptor in Human Colorectal Adenoma: A Validation Study of Tissue Microarrays. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1719-1726. https://doi.org/10.1158/1055-9965.EPI-05-0946.
  14. Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biological-image analysis. Nature Methods. 2012;9(7):676-682. doi:10.1038/nmeth.2019.
  15. Poslavska OV. [The methodology of using software for the analysis of digital photomicrographs based on the course of pathomorphology in order to improve the professional level of students and scientists]. Morphology. 2015;9(3):122-126. Ukrainian.
  16. Poslavska OV. [Determining the linear dimensions and areas of individual morphological objects on photomicrographs using the ImageJ program. Morphology]. 2016;10(3):377-381. Ukrainian.
  17. Melling N, Kowitz CM, Simon R, et al. High Ki67 expression is an independent good prognostic marker in colorectal cancer. J Clin Pathol. 2016;69:209-214. https://doi:10.1136/jclinpath-2015-202985.

Downloads

Published

2022-12-15

How to Cite

Kharkhalis , I., Shponka , I., & Poslavska , O. (2022). Evaluation of the expression of β-catenin and cyclin D1 markers depending on the clinical and morphological characteristics and proliferative activity of colorectal carcinomas. Морфологія / Morphologia / Morfologìâ, 16(4), 32–40. https://doi.org/10.26641/1997-9665.2022.4.32-40

Issue

Vol. 16 No. 4 (2022)

Section

Статті

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.